Cargando…
Tumors Responsive to Autophagy-Inhibition: Identification and Biomarkers
SIMPLE SUMMARY: Although the principle of personalized medicine has been the focus of attention, many cancer therapies are still based on a one-size-fits-all approach. The same holds true for targeting cancer cell survival mechanism that allows cancer cells to recycle their constituents (autophagy)....
Autores principales: | Barbeau, Lydie M.O., Keulers, Tom G.H., Rouschop, Kasper M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563256/ https://www.ncbi.nlm.nih.gov/pubmed/32878084 http://dx.doi.org/10.3390/cancers12092463 |
Ejemplares similares
-
Autophagy-Dependent Secretion: Contribution to Tumor Progression
por: Keulers, Tom G., et al.
Publicado: (2016) -
ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer
por: Keulers, Tom G., et al.
Publicado: (2021) -
Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers
por: Zonneveld, Marijke I., et al.
Publicado: (2019) -
Secretion of pro‐angiogenic extracellular vesicles during hypoxia is dependent on the autophagy‐related protein GABARAPL1
por: Keulers, Tom G., et al.
Publicado: (2021) -
EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition
por: Jutten, Barry, et al.
Publicado: (2018)